title: [Treatment of esophageal varicose bleeding by percutaneous transhepatic varices obliteration and partial spleen embolization].
abstract: OBJECTIVE
  To study the clinical efficacy of TH glue (cyanoacrylate) obliteration of esophageal varices and partial spleen embolization (PSE) in the treatment of esophageal varices bleeding.
  
  
  METHODS
  TH glue was injected into the gastroesophageal varices and their feeder veins in 84 patients. According to the size of the varices and their blood flow, the TH glue was injected alone or after a steel coil was placed at the ostium of the feeder vein. Sometimes absolute alcohol was also injected into the varices. PSE was performed after the TH glue obliteration in all patients.
  
  
  RESULTS
  (1) The TH glue obliteration was performed on 81 patients with a success rate of 96.4%. Three patients died from the procedure. (2) The left gastric vein coronary, gastric varices, pericardial varices, and lower esophageal veins were obliterated in 38 patients (group 1). Left gastric vein, gastric varices, and pericardial veins were obliterated in 31 patients (group 2). Only the main gastric coronary vein was obliterated in 9 patients (group 3). The disappearance rate of the esophageal varices was 71.1% (27/38), 35.5% (11/31) and 0% (0/9) in the three groups. (3) During a follow-up of 6-49 months, rebleeding occurred in 13 of all 78 (16.7%) patients, and it was 7.9% (3/38), 12.9% (4/31) and 66.7% (6/9) respectively in the three groups.
  
  
  CONCLUSIONS
  Our results suggest percutaneous transhepatic TH glue obliteration of esophageal varices and PSE are safe and effective in treating gastroesophageal varicose bleeding.
authors.affiliation: Department of Gastroenterology, Shandong Provincial Hospital, Jinan 250021, China. zhchqing@medmail.com.cn
authors.forename: Chun-qing
authors.initials: CQ
authors.lastname: Zhang
authors.forename: Fu-li
authors.initials: FL
authors.lastname: Liu
authors.forename: Hong-wei
authors.initials: HW
authors.lastname: Xu
authors.forename: Kai
authors.initials: K
authors.lastname: Feng
authors.forename: Lin
authors.initials: L
authors.lastname: Xu
authors.forename: Yu-hua
authors.initials: YH
authors.lastname: Zhu
authors.forename: Jun-yong
authors.initials: JY
authors.lastname: Zhang
authors.forename: Qiang
authors.initials: Q
authors.lastname: Zhu
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D003131:Combined Modality Therapy; D003487:Cyanoacrylates / Q000627:therapeutic use*; D004621:Embolization, Therapeutic / Q000379:methods*; D004932:Esophageal and Gastric Varices / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013154:Spleen; D014014:Tissue Adhesives / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D003487:Cyanoacrylates; D014014:Tissue Adhesives